Vasomotor hot flushes and 24-hour ambulatory blood pressure in recently post-menopausal women

Annals of Medicine

Volumn 42, Issue 3, 2010, Pages 216-222

  Tuomikoski, Pauliina ^a   Haapalahti, Petri ^a   Ylikorkala, Olavi ^a   Mikkola, Tomi S ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

Ambulatory blood pressure; Cardiovascular risk; Heart rate; Menopause; Vasomotor symptoms

Indexed keywords

ADULT; ARTICLE; BLOOD PRESSURE MONITORING; CARDIOVASCULAR RISK; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; FEMALE; HEART FAILURE; HEART RATE; HOT FLUSH; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MENOPAUSE; POSTMENOPAUSE; PRIORITY JOURNAL; SYSTOLIC BLOOD PRESSURE; VASOMOTOR DISORDER;

BLOOD PRESSURE; ESTRADIOL; ESTRONE; FEMALE; FOLLICLE STIMULATING HORMONE; HEART RATE; HOT FLASHES; HUMANS; MIDDLE AGED; POSTMENOPAUSE; PROSPECTIVE STUDIES; QUESTIONNAIRES; TIME FACTORS; TREATMENT OUTCOME;

EID: 77950850446     PISSN: 07853890     EISSN: 13652060     Source Type: Journal    
DOI: 10.3109/07853891003657319     Document Type: Article

References (44)

1. Zanchetti A, Facchetti R, Cesana GC, Modena MG, Pirrelli A, Sega R, et al. Menopause-related blood pressure increase and its relationship to age and body mass index: the SIMONA epidemiological study. J Hypertens. 2005;23:2269-2276 (Pubitemid 41666757)
2. Coylewright M, Reckelhoff JF, Ouyang P. Menopause and hypertension: an age-old debate. Hypertension. 2008;51: 952-959 (Pubitemid 351398967)
3. Barton M, Meyer MR. Postmenopausal hypertension: mechanisms and therapy. Hypertension. 2009;54:11-18
4. Casiglia E, Tikhonoff V, Caffi S, Bascelli A, Schiavon L, Guidotti F, et al. Menopause does not affect blood pressure and risk profi le, and menopausal women do not become similar to men. J Hypertens. 2008;26:1983-1992
5. Cifkova R, Pitha J, Lejskova M, Lanska V, Zecova S. Blood pressure around the menopause: a population study. J Hypertens. 2008;26:1976-1982
6. Mikkola TS, Ylikorkala O. Hormone therapy and cardiovascular disease--still much to be learnt. Gynecol Endocrinol. 2005;20:116-120 (Pubitemid 40604028)
7. van der Schouw YT, Grobbee DE. Menopausal complaints, oestrogens, and heart disease risk: an explanation for discrepant findings on the benefi ts of post-menopausal hormone therapy. Eur Heart J. 2005;26:1358-1361
8. Mendelsohn ME, Karas RH. HRT and the young at heart. N Engl J Med. 2007;356:2639-2641
9. Pinkerton JV, Stovall DW. Is there an association between vasomotor symptoms and both low bone density and cardiovascular risk? Menopause. 2009;16:219-223
10. Freedman RR, Dinsay R. Clonidine raises the sweating threshold in symptomatic but not in asymptomatic postmenopausal women. Fertil Steril. 2000;74:20-23 (Pubitemid 30427267)
11. Freedman RR. Pathophysiology and treatment of menopausal hot fl ashes. Semin Reprod Med. 2005;23:117-125
12. Deecher DC, Dorries K. Understanding the pathophysiology of vasomotor symptoms (hot fl ushes and night sweats) that occur in perimenopause, menopause, and postmenopause life stages. Arch Womens Ment Health. 2007;10:247-257
13. Grady D, Rubin SM, Petitti DB, Fox CS, Black D, Ettinger B, et al. Hormone therapy to prevent disease and prolong life in postmenopausal women. Ann Intern Med. 1992;117: 1016-1037
14. Grodstein F, Manson JE, Colditz GA, Willett WC, Speizer FE, Stampfer MJ. A prospective, observational study of postmenopausal hormone therapy and primary prevention of cardiovascular disease. Ann Intern Med. 2000;133: 933-941 (Pubitemid 32003509)
15. Taskinen MR. Oestrogen replacement therapy and coronary heart disease. Ann Med. 1998;30:443-451 (Pubitemid 28482228)
16. Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML, et al. Risks and benefi ts of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. JAMA. 2002;288:321-333 (Pubitemid 34761611)
17. Manson JE, Hsia J, Johnson KC, Rossouw JE, Assaf AR, Lasser NL, et al. Estrogen plus progestin and the risk of coronary heart disease. N Engl J Med. 2003;349:523-534 (Pubitemid 36951364)
18. Hulley S, Grady D, Bush T, Furberg C, Herrington D, Riggs B, et al. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group. JAMA. 1998;280:605-613
19. Grady D, Herrington D, Bittner V, Blumenthal R, Davidson M, Hlatky M, et al. Cardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II). JAMA. 2002; 288:49-57. (Pubitemid 34705518)
20. Nair GV, Klein KP, Herrington DM. Assessing the role of oestrogen in the prevention of cardiovascular disease. Ann Med. 2001;33:305-312 (Pubitemid 32675369)
21. Hodis HN, Mack WJ. Postmenopausal hormone therapy and cardiovascular disease in perspective. Clin Obstet Gynecol. 2008;51:564-580
22. Mikkola TS, Clarkson TB. Estrogen replacement therapy, atherosclerosis, and vascular function. Cardiovasc Res. 2002;53:605-619 (Pubitemid 34175253)
23. Grodstein F, Clarkson TB, Manson JE. Understanding the divergent data on postmenopausal hormone therapy. N Engl J Med. 2003;348:645-650 (Pubitemid 36204960)
24. Mikkola TS, Clarkson TB, Notelovitz M. Postmenopausal hormone therapy before and after the women's health initiative study: what consequences? Ann Med. 2004;36: 402-413 (Pubitemid 39334842)
25. Gerber LM, Sievert LL, Warren K, Pickering TG, Schwartz JE. Hot fl ashes are associated with increased ambulatory systolic blood pressure. Menopause. 2007;14:308-315 (Pubitemid 46673483)
26. Gast GC, Grobbee DE, Pop VJ, Keyzer JJ, Wijnands-van Gent CJ, Samsioe GN, et al. Menopausal complaints are associated with cardiovascular risk factors. Hypertension. 2008;51:1492-1498
27. Thurston RC, Sutton-Tyrrell K, Everson-Rose SA, Hess R, Matthews KA. Hot fl ashes and subclinical cardiovascular disease: findings from the Study of Women's Health Across the Nation heart study. Circulation. 2008;118:1234-1240
28. Notelovitz M, Lenihan JP, McDermott M, Kerber IJ, Nanavati N, Arce J. Initial 17beta-estradiol dose for treating vasomotor symptoms. Obstet Gynecol. 2000;95:726-731 (Pubitemid 30210060)
29. Sloan JA, Loprinzi CL, Novotny PJ, Barton DL, Lavasseur BI, Windschitl H. Methodologic lessons learned from hot fl ash studies. J Clin Oncol. 2001;19:4280-4290 (Pubitemid 33096775)
30. Panay N, Ylikorkala O, Archer DF, Gut R, Lang E. Ultra-low-dose estradiol and norethisterone acetate: effective menopausal symptom relief. Climacteric. 2007;10: 120-131 (Pubitemid 46482176)
31. Tuomikoski P, Mikkola TS, Hämäläinen E, Tikkanen MJ, Turpeinen U, Ylikorkala O. Biochemical markers for cardiovascular disease in recently postmenopausal women with and without hot fl ashes. Menopause. 2009;17:145-151
32. Pickering TG, Shimbo D, Haas D. Ambulatory bloodpressure monitoring. N Engl J Med. 2006;354:2368-2374
33. Tuomikoski P, Ebert P, Groop PH, Haapalahti P, Hautamäki H, Rönnback M, et al. Evidence for a role of hot fl ushes in vascular function in recently postmenopausal women. Obstet Gynecol. 2009;113:902-908
34. Gold EB, Sternfeld B, Kelsey JL, Brown C, Mouton C, Reame N, et al. Relation of demographic and lifestyle factors to symptoms in a multi-racial/ethnic population of women 40-55 years of age. Am J Epidemiol. 2000;152:463-473
35. Brown DE, Sievert LL, Aki SL, Mills PS, Etrata MB, Paopao RN, et al. Effects of age, ethnicity and menopause on ambulatory blood pressure: Japanese-American and Caucasian school teachers in Hawaii. Am J Hum Biol. 2001; 13:486-493
36. James GD, Sievert LL, Flanagan E. Ambulatory blood pressure and heart rate in relation to hot fl ash experience among women of menopausal age. Ann Hum Biol. 2004; 31:49-58. (Pubitemid 38131690)
37. Low DA, Davis SL, Keller DM, Shibasaki M, Crandall CG. Cutaneous and hemodynamic responses during hot fl ashes in symptomatic postmenopausal women. Menopause. 2008; 15:290-295 (Pubitemid 351354990)
38. Nelesen R, Krohn P, Dimsdale JE. Hot-fl ash hypotension. N Engl J Med. 2004;351:1577-1579
39. Vongpatanasin W. Autonomic regulation of blood pressure in menopause. Semin Reprod Med. 2009;27:338-345
40. Koh KK. Effects of estrogen on the vascular wall: vasomotor function and infl ammation. Cardiovasc Res. 2002;55: 714-726
41. Lewington S, Clarke R, Qizilbash N, Peto R, Collins R; Prospective Studies Collaboration. Age-specifi c relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet. 2002;360:1903-1913 (Pubitemid 35472129)
42. Kshirsagar AV, Carpenter M, Bang H, Wyatt SB, Colindres RE. Blood pressure usually considered normal is associated with an elevated risk of cardiovascular disease. Am J Med. 2006; 119:133-141 (Pubitemid 43151479)
43. Zaydun G, Tomiyama H, Hashimoto H, Arai T, Koji Y, Yambe M, et al. Menopause is an independent factor augmenting the age-related increase in arterial stiffness in the early postmenopausal phase. Atherosclerosis. 2006;184: 137-142 (Pubitemid 41721080)
44. Collins P, Rosano G, Casey C, Daly C, Gambacciani M, Hadji P, et al. Management of cardiovascular risk in the peri-menopausal woman: a consensus statement of European cardiologists and gynaecologists. Eur Heart J. 2007; 28:2028-2040 (Pubitemid 47579557)